GLP-1s may be the first real human enhancement drug.

Dr. Anant Vinjamoori - longevity physician and healthtech entrepreneur - explains why GLP-1s matter far beyond weight loss, why they may be the first drug class seriously crossing into longevity medicine, and why they could be a wedge into next-gen peptides, programable biology, and AI-driven human upgrades.

Hosted by Mgoes → https://x.com/m_goes_distance

Brought to you by SuperHuman Fund → https://superhuman.fund/

---

0:00 - Health → Human Enhancement?

5:37 - GLP-1s: The Real Novelty

8:23 - Next Gen Drugs, Peptides

13:29 - Un*ucking Regulation

22:50 - Health Influencers & Hype

29:23 - Social Media vs AI Discovery

35:46 - GLP1s = Prozac?

41:35 - Biotech Is The Answer

48:19 - AI Drug Discovery

---

The Accelerate Bio Podcast explores the future of humanity in the age of Artificial Intelligence. Subscribe for deep-dive conversations with founders, scientists, and investors shaping AI, biotechnology, and human progress.

---

This episode discusses GLP-1s, GLP-1 drugs, semaglutide, tirzepatide, longevity medicine, human enhancement, Dr Anant Vinjamoori, peptides, anti aging, healthspan, lifespan, metabolic health, obesity drugs, biotechnology, AI drug discovery, programmable biology, cell signaling, longevity biotech, future of healthcare, precision medicine.